Health Affairs, 23, no. 1 (2004): 51 doi: 10.1377/hlthaff.23.1.51 © 2004 by Project HOPE	New Online   House Health Reform Bill   Paying for Reform   Vetting AHIP's Report   HIV/AIDS Costs   Brief: Insurance Reform   HA Blog Top 10

This Article Full Text (HTML) Reprint (PDF) Submit a response to this article Alert me when this article is cited Alert me when Comments are posted Alert me if a correction is posted Services E-mail this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to My Personal Archive Download to Citation Manager Reprints & Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Search for Related Content

Environment

The Evolving Environment For Prescription Drugs

PROLOGUE: As the role of prescription drugs in health care and spending grows, patients, providers, and payers confront a fresh set of dilemmas about the inevitable trade-offs between cost and access. Participants and observers in the policy arena, after striving for years to master the arcana of health services research and the insurance business, must now learn the ropes in a whole new universe of scientific endeavor. The following three papers provide strategic intelligence about changes in the institutional and scientific environment where pharmaceutical research and development occurs.

Regulation by the U.S. Food and Drug Administration (FDA) is the cornerstone . . . [Full Text of this Article]

                      What's this?